Credit Suisse’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$410K Hold
66,489
﹤0.01% 2721
2023
Q4
$521K Sell
66,489
-2,139
-3% -$13.8K ﹤0.01% 2706
2023
Q3
$471K Sell
68,628
-6,618
-9% -$53.6K ﹤0.01% 2712
2023
Q2
$687K Buy
+75,246
New +$625K ﹤0.01% 2622
2023
Q1
Sell
-3
Closed -$15 3532
2022
Q4
$15 Sell
3
-410
-99% -$2.54K ﹤0.01% 3683
2022
Q3
$3K Buy
+413
New +$2.88K ﹤0.01% 3674

Other funds holding LFST

Credit Suisse's LFST Position: Q1 2024 in Review

Credit Suisse held its Lifestance Health (LFST) position steady in Q1 2024 at 66,489 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #2721.

Credit Suisse first reported a position in LFST in Q3 2022 and has held it in 6 quarters since. The position peaked at $687K in Q2 2023. 124 funds tracked by Wall St. Rank hold LFST as of Q1 2024.

  • Credit Suisse held 66,489 shares of Lifestance Health worth $410K as of Q1 2024.
  • Credit Suisse left its Lifestance Health share count unchanged in Q1 2024.
  • Lifestance Health made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2721 holding.
  • Credit Suisse first reported a position in Lifestance Health in Q3 2022 and has held it in 6 quarters since.
  • Credit Suisse's Lifestance Health position peaked at $687K in Q2 2023.
  • 124 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.